La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Cogstate Gestione
Gestione criteri di controllo 3/4
Cogstate's CEO is Brad O'Connor, appointed in Dec 2005, has a tenure of 18.67 years. total yearly compensation is $1.10M, comprised of 33.1% salary and 66.9% bonuses, including company stock and options. directly owns 2.6% of the company’s shares, worth A$5.15M. The average tenure of the management team and the board of directors is 3.5 years and 3.8 years respectively.
Informazioni chiave
Brad O'Connor
Amministratore delegato
US$1.1m
Compenso totale
| Percentuale dello stipendio del CEO | 33.1% |
| Mandato del CEO | 18.7yrs |
| Proprietà del CEO | 2.6% |
| Durata media del management | 3.5yrs |
| Durata media del Consiglio di amministrazione | 3.8yrs |
Aggiornamenti recenti sulla gestione
Recent updates
There's Been No Shortage Of Growth Recently For Cogstate's (ASX:CGS) Returns On Capital
Jul 26
If EPS Growth Is Important To You, Cogstate (ASX:CGS) Presents An Opportunity
May 13The Price Is Right For Cogstate Limited (ASX:CGS)
Jan 17Is Cogstate Limited (ASX:CGS) Trading At A 29% Discount?
Jul 26Returns Are Gaining Momentum At Cogstate (ASX:CGS)
Apr 14Growth Investors: Industry Analysts Just Upgraded Their Cogstate Limited (ASX:CGS) Revenue Forecasts By 11%
Mar 23Earnings Update: Cogstate Limited (ASX:CGS) Just Reported And Analysts Are Trimming Their Forecasts
Mar 02Cogstate Limited (ASX:CGS) Shares Could Be 19% Below Their Intrinsic Value Estimate
Jan 13Investors Appear Satisfied With Cogstate Limited's (ASX:CGS) Prospects As Shares Rocket 51%
Oct 04Do Cogstate's (ASX:CGS) Earnings Warrant Your Attention?
Sep 28Returns On Capital Are A Standout For Cogstate (ASX:CGS)
Sep 02We Ran A Stock Scan For Earnings Growth And Cogstate (ASX:CGS) Passed With Ease
Jun 30Investors Should Be Encouraged By Cogstate's (ASX:CGS) Returns On Capital
Mar 22We Think Some Shareholders May Hesitate To Increase Cogstate Limited's (ASX:CGS) CEO Compensation
Oct 20Cogstate (ASX:CGS) Is Looking To Continue Growing Its Returns On Capital
Jul 23Is Cogstate (ASX:CGS) Using Too Much Debt?
Apr 29What Can The Trends At Cogstate (ASX:CGS) Tell Us About Their Returns?
Mar 14Here's What Cogstate Limited's (ASX:CGS) Shareholder Ownership Structure Looks Like
Feb 21
How Much Is Cogstate's (ASX:CGS) CEO Getting Paid?
Jan 17Can You Imagine How Jubilant Cogstate's (ASX:CGS) Shareholders Feel About Its 214% Share Price Gain?
Dec 05Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | US$6m |
| Sep 30 2023 | n/a | n/a | US$5m |
| Jun 30 2023 | US$1m | US$363k | US$4m |
| Mar 31 2023 | n/a | n/a | US$4m |
| Dec 31 2022 | n/a | n/a | US$3m |
| Sep 30 2022 | n/a | n/a | US$6m |
| Jun 30 2022 | US$2m | US$346k | US$8m |
| Mar 31 2022 | n/a | n/a | US$9m |
| Dec 31 2021 | n/a | n/a | US$10m |
| Sep 30 2021 | n/a | n/a | US$7m |
| Jun 30 2021 | US$1m | US$344k | US$5m |
| Mar 31 2021 | n/a | n/a | US$3m |
| Dec 31 2020 | n/a | n/a | US$335k |
| Sep 30 2020 | n/a | n/a | -US$811k |
| Jun 30 2020 | US$931k | US$371k | -US$2m |
| Mar 31 2020 | n/a | n/a | -US$3m |
| Dec 31 2019 | n/a | n/a | -US$3m |
| Sep 30 2019 | n/a | n/a | -US$3m |
| Jun 30 2019 | US$655k | US$368k | -US$2m |
| Mar 31 2019 | n/a | n/a | -US$2m |
| Dec 31 2018 | n/a | n/a | -US$1m |
| Sep 30 2018 | n/a | n/a | -US$907k |
| Jun 30 2018 | US$783k | US$338k | -US$566k |
Compensazione vs Mercato: Brad's total compensation ($USD1.10M) is above average for companies of similar size in the Australian market ($USD299.11K).
Compensazione vs guadagni: Brad's compensation has been consistent with company performance over the past year.
AMMINISTRATORE DELEGATO
Brad O'Connor
18.7yrs
Mandato
US$1,098,299
Compensazione
Mr. Bradley John O'Connor, also known as Brad, B.Bus, CA, has been the Chief Executive Officer and Managing Director of Cogstate Limited since December 1, 2005 and served as its Chief Financial Officer sin...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, MD & Executive Director | 18.7yrs | US$1.10m | 2.6% $ 5.1m | |
| Founder & Chief Innovation Officer | no data | Nessun dato | Nessun dato | |
| Chief Financial Officer | 3.5yrs | US$469.06k | Nessun dato | |
| Chief Technology Officer | 3.6yrs | US$311.03k | Nessun dato | |
| Chief Science Officer | 3.8yrs | US$421.93k | 0.029% $ 58.0k | |
| Chief Commercial Officer | 4.8yrs | US$436.14k | Nessun dato | |
| Executive VP of Clinical Trials | 1.2yrs | US$302.28k | 0.059% $ 116.0k | |
| General Counsel | 1.3yrs | Nessun dato | Nessun dato | |
| Joint Company Secretary | 3.5yrs | Nessun dato | Nessun dato |
3.5yrs
Durata media
Gestione esperta: CGS's management team is considered experienced (3.5 years average tenure).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, MD & Executive Director | 18.7yrs | US$1.10m | 2.6% $ 5.1m | |
| General Counsel | no data | Nessun dato | Nessun dato | |
| Independent Non-Executive Director | 14yrs | US$56.15k | 2.61% $ 5.2m | |
| Non-Executive Chairman | 24.7yrs | US$94.62k | 27.18% $ 53.8m | |
| Independent Non-Executive Director | 5yrs | US$70.97k | 0.079% $ 155.6k | |
| Independent Non-Executive Director | 3.8yrs | US$64.21k | 0.0074% $ 14.6k | |
| Independent Non-Executive Director | 7.6yrs | US$62.76k | 0.039% $ 77.7k | |
| Member of Scientific Advisory Board | 2.2yrs | Nessun dato | Nessun dato | |
| Distinguished Medical Adviser & Chairman of Scientific Advisory Board | 2.2yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | 2.2yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | 2.2yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | 2.2yrs | Nessun dato | Nessun dato |
3.8yrs
Durata media
62yo
Età media
Consiglio di amministrazione esperto: CGS's board of directors are considered experienced (3.8 years average tenure).